Loading... Please wait...
Sort by:
  • Pages:
  • 1
  • 2
  • 3
  • Digital Biomarkers: Pharma’s clinical development future?
    Learn More Digital Biomarkers: Pharma’s clinical development future?
    Assessing digital biomarker applications that could radically impact pharma's clinical research practice By precisely and continuously measuring disease symptoms, digital biomarkers can allow pharma to establish valid...
  • Telemedicine’s Move into the Mainstream
    Learn More Telemedicine’s Move into the Mainstream
    COVID-19 accelerated uptake of telemedicine is rapidly transforming healthcare delivery Telemedicine is one major success story of the pandemic. Barriers previously hindering widespread adoption of telehealth practices...
  • COVID-19 Implications for pharma: US payer insights
    Learn More COVID-19 Implications for pharma: US payer insights
    What are the implications for pharma as COVID-19 forces fundamental change in US payer practice and policy? The COVID-19 pandemic has created a unique set of challenges for US payers. In the short-term emergency...
  • The MSL Technology Survey (2020)
    Learn More The MSL Technology Survey (2020)
    With physical distancing currently the norm, MSLs must radically change their working practice to effectively engage with KOLs Face-to-face meetings are the preferred choice of MSLs when sharing key scientific...
  • Injectables and Implantables
    Learn More Injectables and Implantables
    Injectables and implantables are key to advancing patient centricity and adherence The development of controlled and prolonged release injectable and implantable drugs has seen huge leaps forward in recent years...
  • The Digitisation of Diabetes: Opportunities and Challenges for Industry
    Learn More The Digitisation of Diabetes: Opportunities and Challenges for Industry
    Assessing the revolutionary impact of digital technologies on the management of diabetes Advanced digital technologies and devices are driving fundamental change in the management of both Type 1 and 2...
  • Digital Technologies: New Strategies for Customer Engagement
    Learn More Digital Technologies: New Strategies for Customer Engagement
    Digital technology is transforming customer engagement Pharma has embraced the digital revolution with open arms—clearly it offers exciting new opportunities for customer engagement. But initial enthusiasm...
  • Paying for Digital Health: Payer Insights (2019)
    Learn More Paying for Digital Health: Payer Insights (2019)
    Which digital health technologies are exciting payers? How and where can digital health technology improve patient outcomes and save payers money? Across the digital health field there are hundreds of applications...
  • Real World Evidence: The Role of Medical Affairs
    Learn More Real World Evidence: The Role of Medical Affairs
    How well has RWE integrated into Medical Affairs—and should more be done? Payers and other stakeholders increasingly expect to see real world evidence (RWE) to support their decision making. Since being added to...
  • AI in Medical Diagnostics
    Learn More AI in Medical Diagnostics
    Evaluating the potential of artificial intelligence to revolutionise and expand medical diagnostics Artificial intelligence (AI) driven technologies have already radically changed practice and outcomes in medical...
  • Health Insurance Disruptors: Going Digital
    Learn More Health Insurance Disruptors: Going Digital
    Health insurance: how to thrive in an increasingly digital health world Health insurers are being challenged to develop a portfolio of digital services with limited knowledge of their effectiveness and at a considerable...
  • Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)
    Learn More Innovative drugs: Mapping the Pricing and Reimbursement Landscape (2020)
    Drug innovation is delivering highly-effective medicines that significantly improve patient outcomes and, in some cases, are curative of disease. Yet of the 55 medicines that were approved in the US between January 2018...
  • Interoperability in Health
    Learn More Interoperability in Health
    Experts agree interoperability will unlock considerable value across healthcare Interoperability—enabling information systems to share data—offers a wealth of opportunities for multiple health stakeholders,...
  • Pricing Transparency in Pharma
    Learn More Pricing Transparency in Pharma
    Pharma challenged to engage and shape the drug pricing transparency debate Anxieties about rising drug prices is fuelling an ever louder global demand for price transparency—and reformers are getting their message...
  • The Future of Personalised Medicine: The Role of Simulation and Digital Twins
    Learn More The Future of Personalised Medicine: The Role of Simulation and Digital Twins
    Beyond the hype, where might simulation and digital twin technology deliver value for pharma? There is considerable excitement about the potential for simulation and digital twin technology to drive the personalised...
  • The Impact of 5G on Healthcare
    Learn More The Impact of 5G on Healthcare
    Health insurance: how to thrive in an increasingly digital health world 5G wireless network technology has the potential to revolutionise pharma's business. Combined with advances in artificial intelligence and machine...
  • Pages:
  • 1
  • 2
  • 3

customer.service@firstwordpharma.com

All Contents Copyright © 2020 Doctor's Guide Publishing Limited All Rights Reserved